BCM
MJN

Bayesian Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Bayesian Capital Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,900
Closed -$501K – 615
2016
Q1 		$501K Buy
+5,900
New +$439K 0.47% 38

Other funds holding MJN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bayesian Capital Management's MJN Position: Q2 2016 in Review

Bayesian Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2016, closing a stake of 5,900 shares — an estimated $501K sold.

Bayesian Capital Management first reported a position in MJN in Q1 2016 and held it in 1 quarter. The position peaked at $501K in Q1 2016. 545 funds tracked by Wall St. Rank hold MJN as of Q2 2016.

  • Bayesian Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2016 after selling out during the quarter.
  • Bayesian Capital Management sold 5,900 Mead Johnson Nutrition Company shares in Q2 2016, an estimated $501K.
  • Bayesian Capital Management first reported a position in Mead Johnson Nutrition Company in Q1 2016 and held it in 1 quarter.
  • Bayesian Capital Management's Mead Johnson Nutrition Company position peaked at $501K in Q1 2016.
  • 545 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2016.

Based on Bayesian Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.